Russia develops Delta Omicron-adapted Sputnik V vaccine
Russia Gamaleya National Research Center of Epidemiology and Microbiology (Gamaleya Center) and the Russian Direct Investment Fund announced the development o
United States Russia Gamaleya National Research Center Gamaleya Center Microbiology Gamaleya Center Russian Direct Investment Fund Gamaleya National Research Center
Source: russiaherald.com